Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-31 Purchase | 2023-11-02 9:21 pm | Eiger BioPharmaceuticals Inc. | EIGR | KAYNE RICHARD A 10% Owner | 278,239 | $0.2617 | $72,815 | 5,375,225 (Indirect) | View |
| 2023-10-31 Purchase | 2023-11-02 9:14 pm | Eiger BioPharmaceuticals Inc. | EIGR | KAWAS LEEN 10% Owner | 24,332 | $0.26199 | $6,375 | 4,391,432 (Indirect) | View |
| 2023-03-17 Sale | 2023-03-21 9:00 pm | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 4,395 | $1.0703 | $4,704 | 56,073 (Direct) | View |
| 2023-01-23 Purchase | 2023-01-25 8:54 pm | Eiger BioPharmaceuticals Inc. | EIGR | Dietz Thomas John Director | 50,000 | $1.4316 | $71,580 | 71,000 (Indirect Direct) | View |
| 2022-12-29 Sale | 2023-01-03 8:30 pm | Eiger BioPharmaceuticals Inc. | EIGR | Murray Christine Director | 5,000 | $1.2208 | $6,104 | 11,000 (Direct) | View |
| 2022-12-22 Sale | 2022-12-27 5:31 pm | Eiger BioPharmaceuticals Inc. | EIGR | Dietz Thomas John Director | 22,500 | $1.169 | $26,303 | 21,000 (Direct) | View |
| 2022-12-22 Purchase | 2022-12-27 5:31 pm | Eiger BioPharmaceuticals Inc. | EIGR | Glenn Jeffrey S Director | 100,000 | $1.2795 | $127,950 | 338,879 (Indirect Direct) | View |
| 2022-08-16 Sale | 2022-08-18 5:36 pm | Eiger BioPharmaceuticals Inc. | EIGR | Apelian David Director | 5,000 | $9.8061 | $49,031 | 11,000 (Direct) | View |
| 2022-03-14 Sale | 2022-03-14 9:22 pm | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 2,266 | $5.5973 | $12,683 | 41,566 (Direct) | View |
| 2022-03-14 Sale | 2022-03-14 9:21 pm | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 1,657 | $5.5973 | $9,275 | 60,468 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-10-30 4:53 pm | N/A N/A | Eiger BioPharmaceuticals Inc. | EIGR | KAYNE RICHARD A 10% Owner | 0 | $0 | 5,096,986 (Indirect) | View |
Ownership | 2023-10-30 4:51 pm | N/A N/A | Eiger BioPharmaceuticals Inc. | EIGR | KAWAS LEEN 10% Owner | 0 | $0 | 4,367,100 (Indirect) | View |
| 2023-08-31 Option Award | 2023-09-05 9:38 pm | N/A 2033-08-30 | Eiger BioPharmaceuticals Inc. | EIGR | Choong Ingrid Chief Business Officer | 54,000 | $0 | 54,000 (Direct) | View |
Ownership | 2023-09-05 9:35 pm | N/A N/A | Eiger BioPharmaceuticals Inc. | EIGR | Choong Ingrid Chief Business Officer | 0 | $0 | 446,191 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-06 5:37 pm | N/A 2033-07-02 | Eiger BioPharmaceuticals Inc. | EIGR | Apelian David CEO | 750,000 | $0 | 750,000 (Direct) | View |
| 2023-04-30 Option Award | 2023-05-02 4:30 pm | N/A 2033-04-29 | Eiger BioPharmaceuticals Inc. | EIGR | Vollins James General Counsel | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:50 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Sachdev Amit Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:50 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:50 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Murray Christine Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:50 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Glenn Jeffrey S Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:50 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Sablich Kim Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:49 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Kelly-Croswell Lisa Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:49 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 98,000 | $0 | 98,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:49 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Dietz Thomas John Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 9:12 pm | N/A 2033-01-31 | Eiger BioPharmaceuticals Inc. | EIGR | Apelian David Interim CEO | 170,000 | $0 | 170,000 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 9:25 pm | N/A 2033-01-26 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 31,500 | $0 | 31,500 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 9:15 pm | N/A 2033-01-26 | Eiger BioPharmaceuticals Inc. | EIGR | Atkisson Erik GC & Chief Compliance Officer | 26,750 | $0 | 26,750 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-19 7:02 pm | N/A 2032-07-17 | Eiger BioPharmaceuticals Inc. | EIGR | Kelly-Croswell Lisa Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:07 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Sachdev Amit Director | 18,000 | $0 | 28,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Sablich Kim Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 167,000 | $0 | 186,832 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Murray Christine Director | 18,000 | $0 | 28,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 114,000 | $0 | 160,125 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Glenn Jeffrey S Director | 18,000 | $0 | 250,879 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director | 18,000 | $0 | 26,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Dietz Thomas John Director | 30,000 | $0 | 67,500 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Cory David A President and CEO | 328,000 | $0 | 450,183 (Direct) | View |